EV/EBITDA
-2.14
+0.02+0.93%
Fri, 07 Feb 2025 23:13:29 GMT
Summary
- As of February 8, 2025, CMMB EV/EBITDA is -2.14, with a rise of +0.02 (+0.93%) during the most recent trading day.
- Over the past year, CMMB EV/EBITDA has dropped by -2.16 (-10800.00%).
- CMMB EV/EBITDA is now -813.33% below its all-time high of 0.30.
Performance
CMMB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CMMB EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.9% | -0.6% | -0.5% |
| 1 m1 month | +8.2% | -7.9% | -6.8% |
| 3 m3 months | -55.1% | +55.0% | +42.5% |
| 6 m6 months | -148.8% | +138.6% | +108.2% |
| ytdytd | -18.9% | +19.1% | +15.6% |
| 1 y1 year | -10000.0% | +8491.6% | +247.3% |
| 5 y5 years | - | - | -89.9% |
CMMB EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -11.5% | -2.38 | +10.1% | |
| 3 m | 3-month | -1.38 | -55.1% | -2.50 | +14.4% |
| 6 m | 6-month | -0.77 | -177.9% | -2.58 | +17.1% |
| 1 y | 1-year | 0.03 | -7233.3% | -2.58 | +17.1% |
| 3 y | 3-year | 0.30 | -813.3% | -3.71 | +42.3% |
| 5 y | 5-year | 0.30 | -813.3% | -32.26 | +93.4% |
| alltime | all time | 0.30 | -813.3% | -32.26 | +93.4% |
Chemomab Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.14(+18.9%) |
| 2024 | -1.80(-2671.4%) |
| Date | Value |
|---|---|
| 2023 | 0.07(-109.1%) |
| 2022 | -0.77(-85.1%) |
| 2021 | -5.18 |
FAQ
- What is Chemomab Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Chemomab Therapeutics?
- What is CMMB EV/EBITDA year-to-date change?
- What is Chemomab Therapeutics EV/EBITDA year-on-year change?
What is Chemomab Therapeutics EV/EBITDA?
The current EV/EBITDA of CMMB is -2.14
What is the all time high EV/EBITDA for Chemomab Therapeutics?
Chemomab Therapeutics all-time high EV/EBITDA is 0.30
What is CMMB EV/EBITDA year-to-date change?
Chemomab Therapeutics EV/EBITDA has changed by -0.34 (-18.89%) since the beginning of the year
What is Chemomab Therapeutics EV/EBITDA year-on-year change?
Over the past year, CMMB EV/EBITDA has changed by -2.16 (-10800.00%)